Dapiglutide, a dual GLP-1 and GLP-2 receptor agonist, for obesity: a randomised, double-blind, placebo-controlled parallel-group, proof-of-concept trial
达匹鲁肽(一种双重 GLP-1 和 GLP-2 受体激动剂)治疗肥胖症:一项随机、双盲、安慰剂对照、平行组的概念验证试验
期刊:EClinicalMedicine
影响因子:10
doi:10.1016/j.eclinm.2026.103801
Nielsen, Casper K; Pálsson, Thorir G; Forman, Julie L; Lukacova, Michaela; Jensen, Benjamin A H; Mathiesen, David S; Englund, Anders; Gether, Ida M; Johansen, Nicklas J; Pedersen, Miriam G; Hartmann, Bolette; Holst, Jens J; Knop, Filip K; Lund, Asger B